Utama › Leukemia Limfositik Kronik › Maryland › Baltimore
Kajian klinikal Leukemia Limfositik Kronik di Baltimore, MD
6 kajian untuk Leukemia Limfositik Kronik sedang mencari peserta di lokasi dalam dan sekitar Baltimore (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- dan 2 lagi
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Mengambil pesertaFasa 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Mengambil pesertaFasa 3
- The University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Mengambil pesertaFasa 3
- Johns Hopkins Asthma & Allergy Center, Baltimore
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
Mengambil pesertaFasa 1
- University of Maryland, Baltimore
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Mengambil pesertaFasa 1
- University of Maryland Medical Center - Greenebaum Comprehensive Cancer Center, Baltimore
Kajian Leukemia Limfositik Kronik di bandar lain
- Boston, MA31 kajian
- Columbus, OH28 kajian
- Durham, NC27 kajian
- Washington, DC22 kajian
- Seattle, WA20 kajian
- Rochester, MN19 kajian
- New York City, NY18 kajian
- Houston, TX17 kajian
- Baldwin Park, CA16 kajian
- Milwaukee, WI15 kajian
- Cincinnati, OH14 kajian
- Chicago, IL14 kajian
Kajian lain di Baltimore
- Kanser Paru-paru Bukan Sel Kecil60 kajian
- Kanser Payudara47 kajian
- Kanser Prostat43 kajian
- Kanser Paru-paru40 kajian
- Kanser (semua jenis)37 kajian
- Kanser Kolorektal31 kajian
- Kanser Pankreas31 kajian
- Kanser Metastatik28 kajian
- Obesiti25 kajian
- Kegagalan Jantung24 kajian
- Kanser Pundi Kencing24 kajian
- Strok22 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.